Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05953519 · ClinicalTrials.gov registry record · NA

Meeting an Unmet Need in Multiple Sclerosis

A NA study of Multiple Sclerosis, sponsored by Kessler Foundation.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT05953519 is a NA study of Multiple Sclerosis that is actively recruiting participants, run by Kessler Foundation. The registered enrollment target is 24 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05953519, a NA study of Multiple Sclerosis, is actively recruiting participants, sponsored by Kessler Foundation.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The primary objectives of this study is to examine the efficacy of the Unified Protocol in decreasing depression and anxiety among individuals with MS and the secondary outcomes (e.g., improved well-being, QOL, coping, etc.) that may occur in tandem.

Conditions Studied

Interventions

  • BEHAVIORAL Unified Protocol

Study Locations (1)

New Jersey

  • Kessler Foundation - East Hanover

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2023-04-10
Est. Completion 2026-04-30
Phase NA

Sponsor

Kessler Foundation

104 total trials

What the Registry Record Tells You About NCT05953519

The ClinicalTrials.gov registry entry for NCT05953519 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (96% lower). The listed sponsor is Kessler Foundation, which has 104 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Unified Protocol is the first listed.

NCT05953519 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT05953519 about?

NCT05953519 is a clinical study titled "Meeting an Unmet Need in Multiple Sclerosis". The primary objectives of this study is to examine the efficacy of the Unified Protocol in decreasing depression and anxiety among individuals with MS and the secondary outcomes (e.g., improved well-being, QOL, coping, etc.) that may occur in tandem.

What is the current status of trial NCT05953519?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2023-04-10. Estimated completion is 2026-04-30.

What conditions does trial NCT05953519 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT05953519?

The interventions under investigation include: Unified Protocol (BEHAVIORAL).

Who is sponsoring clinical trial NCT05953519?

This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05953519 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.